SCYNEXIS, Inc.

SCYX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Feb 2, 2026 4
SCHEDULE 13G/A Jan 8, 2026
SCHEDULE 13G/A Nov 14, 2025
SCHEDULE 13G/A Nov 12, 2025
10-Q Nov 5, 2025 10-Q
4 Oct 21, 2025 4
8-K Oct 15, 2025 8-K
SCHEDULE 13G/A Oct 7, 2025
10-Q Aug 13, 2025 10-Q
8-K Jul 1, 2025 8-K
4 Jun 30, 2025 4
4 Jun 30, 2025 4
4 Jun 30, 2025 4
4 Jun 30, 2025 4
4 Jun 30, 2025 4
4 Jun 30, 2025 4
8-K Jun 26, 2025 8-K
10-Q May 15, 2025 10-Q
ARS Apr 30, 2025 ARS
DEFA14A Apr 30, 2025 DEFA14A
DEF 14A Apr 30, 2025 DEF 14A
4 Apr 10, 2025 4
4 Mar 20, 2025 4
10-K Mar 12, 2025 10-K
SCHEDULE 13G/A Feb 14, 2025
← Newer Page 3 of 30 · 744 filings Older →